Meta-Analysis on Efficacy and Safety of Bivalirudin and Heparin for Anticoagulation in ExtracorporealMembrane Oxygenation in Children and Adolescents

Chang Yuanyuan; Yang Fangyuan; Feng Haoxuan

doi:10.13407/j.cnki.jpp.1672-108X.2024.01.012

您当前的位置：

首页 >

文章列表页 >

Meta-Analysis on Efficacy and Safety of Bivalirudin and Heparin for Anticoagulation in ExtracorporealMembrane Oxygenation in Children and Adolescents

更新时间：2024-01-12

- Meta-Analysis on Efficacy and Safety of Bivalirudin and Heparin for Anticoagulation in ExtracorporealMembrane Oxygenation in Children and Adolescents
- Vol. 30, Issue 1, Pages: 45-50(2024)
- 作者机构：
  
  1. 西安医学院第一附属医院,西安,710082
  2. 宝鸡市中心医院,陕西,宝鸡,721000
  3. 西安交通大学附属红会医院,西安,710000
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2024.01.012
  CLC：
- Published：2024，
扫描看全文
Chang Yuanyuan, Yang Fangyuan, Feng Haoxuan. Meta-Analysis on Efficacy and Safety of Bivalirudin and Heparin for Anticoagulation in ExtracorporealMembrane Oxygenation in Children and Adolescents. [J]. 30(1):45-50(2024)
DOI：

Chang Yuanyuan, Yang Fangyuan, Feng Haoxuan. Meta-Analysis on Efficacy and Safety of Bivalirudin and Heparin for Anticoagulation in ExtracorporealMembrane Oxygenation in Children and Adolescents. [J]. 30(1):45-50(2024) DOI： 10.13407/j.cnki.jpp.1672-108X.2024.01.012.

摘要

目的:系统评价比伐卢定与肝素用于儿童及青少年体外膜肺氧合( ECMO) 抗凝的有效性与安全性。方法:计算机检索 PubMed、the Cochrane Library、EMBase、万方、中国知网(CNKI)及维普(VIP)等数据库

搜集有关比伐卢定与肝素用于儿童及青少年ECMO 抗凝的临床研究

检索时限均为建库至2022 年9 月5 日

由2 名研究者独立筛选文献、提取资料并采用纽卡斯尔-渥太华量表(NOS)对纳入文献进行质量评估

采用Rev Man 5. 4 软件进行Meta 分析。结果:共纳入6 篇回顾性队列研究

包括246 例患儿。Meta 分析结果显示

与肝素比较

比伐卢定显著降低儿童及青少年ECMO 抗凝患儿的出血事件(RR=0. 30

95%CI 0. 15~ 0. 64

P =0. 002)及卒中率(RR=0. 39

95%CI 0. 18~0. 84

P =0. 02)

但病死率(RR=0. 95

95%CI 0. 70~1. 28)、血栓形成发生率 (RR=0. 94

95%CI 0. 34~2. 61)、ECMO 管路干预发生率( RR = 1. 08

95%CI 0. 53 ~ 2. 19)、生存率( RR = 1. 16

95%CI 0. 90 ~ 1. 49)比较差异均无统计学意义。结论:比伐卢定可以显著降低儿童及青少年ECMO 抗凝患儿的出血事件和卒中率

在改善病死率、血栓形成发生率、ECMO 管路干预发生率、生存率方面优势不明显。由于纳入的研究均为回顾性队列研究

因此本Meta 分析的证据水平较低

不可避免存在异质性

迫切需要更高质量的随机双盲对照研究予以验证。

Abstract

Objective: To systematically evaluate the efficacy and safety of bivalirudin and heparin for anticoagulation in extracorporeal membrane oxygenation (ECMO) in children and adolescents. Methods: PubMed

the Cochrane Library

EMBase

Wanfang

CNKI and VIP databases were retrieved for collecting clinical studies of bivalirudin and heparin for anticoagulation in ECMO in children and adolescents. The retrieval time was from the establishment of the database to Sept. 5th

2022. Two researchers independently screened literature

extracted data

and assessed the quality of included studies through the Newcastle-Ottawa Scale (NOS)

and Meta-analysis was performed through Rev Man 5. 4 software. Results: Six retrospective cohort studies including 246 patients were enrolled. Metaanalysis results indicated that compared with heparin

bivalirudin significantly reduced bleeding events (RR=0. 30

95% CI from 0. 15 to 0. 64

P =0. 002) and stroke rates (RR=0. 39

95% CI from 0. 18 to 0. 84

P =0. 02) in children and adolescents undergoing ECMO for anticoagulation

yet there were no statistically significant differences in mortality rate (RR = 0. 95

95% CI from 0. 70 to 1. 28)

incidence of thrombosis (RR=0. 94

95% CI from 0. 34 to 2. 61)

circuit intervention rate of ECMO (RR=1. 08

95% CI from 0. 53 to 2. 19)

and survival rate (RR=1. 16

95% CI from 0. 90 to 1. 49). Conclusion: Bivalirudin significantly reduces bleeding events and stroke rates in children and adolescents undergoing ECMO

yet the advantages in improving mortality rate

incidence of thrombosis

circuit intervention rate of ECMO and survival rate are not evident. As the included studies were retrospective cohort studies

the evidence level of the Meta-analysis is relatively low

inevitably leading to heterogeneity. Further high-quality randomized double-blind controlled studies are urgently needed for validation.

关键词

体外膜肺氧合比伐卢定肝素抗凝儿童青少年Meta 分析

Keywords

extracorporeal membrane oxygenationbivalirudinheparinanticoagulationchildrenadolescentsMeta-analysis

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Influencing Factors of Treatment Compliance in Children with Asthma in China

Analysis of 36 Cases of Drug Poisoning in Children in a Grade III, Level A General Hospital andConsideration on Pharmaceutical Care

Application of Dexmedetomidine Combined with Hydromorphone Nasal Drip in Sedation of Mother-InfantSeparation before Adenoidectomy

Sirolimus in the Treatment of 5 Cases of Blue Rubber Bleb Nevus Syndrome in Children and Literature Review

Systematic Review on Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metabolic Disordersin Children

Related Author

Luo Nan

Wang Ling

Yuan Xiaoping

郭蓉

Wang Peng

Xu Ying

Zhang Xiaoming

Zhang Shaonan

Related Institution

Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics

The Second People’ s Hospital of Anhui Wuhu, Anhui Wuhu

Jiangsu Taizhou People’s Hospital, Jiangsu Taizhou

Children’s Hospital Affiliated to Zhengzhou University,Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou Key Laboratory of Children’s Digestive Diseases

Kunming Children’s Hospital / Children’s Hospital of Kunming Medical University, Kunming

⁰